Consolidated Statements of Cash Flows (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
OPERATING ACTIVITIES
Net income	$ 95.1	$ 268.8	$ 207.4
Reconciliation to net cash provided by operating activities:
Depreciation and amortization	119.0	120.0	115.6
Equity in earnings of unconsolidated affiliate	(18.5)	(15.2)	(17.8)
Dividend received from unconsolidated affiliate	6.3	10.9	0.5
Chapter 11 expenses, net of interest income	16.6	20.0	17.7
Chapter 11 expenses paid	(15.5)	(20.6)	(28.6)
Libby medical program settlement	19.6	0	0
Libby medical program settlement paid	(19.6)	0	0
Provision for asbestos-related contingencies	365.0	0	0
(Benefit from) provision for income taxes	(37.3)	114.7	32.5
Income taxes paid, net of refunds	(82.6)	(44.7)	(13.8)
Tax benefits from stcok-based compensation	(36.8)	0	0
Interest accrued on pre-petition liabilities subject to compromise	40.4	39.0	37.5
Restructuring expenses and related asset impairments	6.9	6.9	11.2
Payments for restructuring expenses	(8.4)	(7.2)	(13.9)
Defined benefit pension expense	71.2	63.4	77.1
Payments under defined benefit pension arrangements	(126.8)	(265.1)	(63.3)
Provision for environmental remediation	3.6	17.8	4.5
Expenditures for environmental remediation	(13.0)	(11.8)	(8.0)
Changes in assets and liabilities, excluding effect of currency translation:
Trade accounts receivable	(3.0)	(80.6)	(15.8)
Inventories	53.9	(66.9)	(37.1)
Accounts payable	(11.7)	52.6	35.5
All other items, net	29.2	17.4	(15.3)
Net cash provided by operating activities	453.6	219.4	325.9
INVESTING ACTIVITIES
Capital expenditures	(138.5)	(144.0)	(111.1)
Businesses acquired, net of cash acquired	(80.0)	(55.8)	(34.7)
Transfer to restricted cash and cash equivalents	(61.1)	(38.8)	(97.8)
Proceeds from sales of product lines	0	10.0	0
Other investing activities	(0.7)	7.7	0.5
Net cash used for nvesting activities	(280.3)	(220.9)	(243.1)
FINANCING ACTIVITIES
Net borrowings under credit arrangements	35.9	21.6	28.9
Proceeds from exercise of stock options	32.2	12.1	10.4
Tax benefits from stock-based compensation	36.8	0	0
Other financing activities	5.4	6.0	2.2
Net cash provided by financing activities	110.3	39.7	41.5
Effect of currency exchange rate changes on cash and cash equivalents	5.0	(5.6)	(1.6)
Increase in cash and cash equivalents	288.6	32.6	122.7
Cash and cash equivalents, beginning of period	1,048.3	1,015.7	893.0
Cash and cash equivalents, end of period	$ 1,336.9	$ 1,048.3	$ 1,015.7